1618. Meropenem-vaborbactam vs standard of care for multidrug resistant carbapenem-resistant Enterobacteriaceae

BACKGROUND: Antimicrobial resistance to gram negative organisms is an increasing issue worldwide, particularly with regards to extended-spectrum B-lactamase (ESBL) and carbapenem-resistant Enterobacteriaeceae (CRE) producing organisms. Meropenem/vaborbactam (M-V) is an approved antimicrobial for tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Misikir, Helina, Mulugeta, Surafel, Shallal, Anita, Zervos, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777637/
http://dx.doi.org/10.1093/ofid/ofaa439.1798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777637/
http://dx.doi.org/10.1093/ofid/ofaa439.1798

Ejemplares similares